Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Inventory Average (2022 - 2025)

Historic Inventory Average for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Q3 2025 value amounting to $23.5 million.

  • Mirum Pharmaceuticals' Inventory Average rose 1172.92% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 1172.92%. This contributed to the annual value of $22.4 million for FY2024, which is 6040.1% up from last year.
  • Mirum Pharmaceuticals' Inventory Average amounted to $23.5 million in Q3 2025, which was up 1172.92% from $22.7 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Inventory Average high stood at $23.5 million for Q3 2025, and its period low was $1.5 million during Q1 2022.
  • Its 4-year average for Inventory Average is $14.8 million, with a median of $21.0 million in 2024.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Inventory Average soared by 29372.78% in 2023, and later crashed by 126.79% in 2024.
  • Mirum Pharmaceuticals' Inventory Average (Quarter) stood at $6.3 million in 2022, then soared by 256.27% to $22.3 million in 2023, then dropped by 1.27% to $22.0 million in 2024, then rose by 6.74% to $23.5 million in 2025.
  • Its Inventory Average was $23.5 million in Q3 2025, compared to $22.7 million in Q2 2025 and $22.4 million in Q1 2025.